Eosinophilic Asthma Biologic — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Mepolizumab or dupilumab
Elevated eosinophils predict response to anti-IL-5 (mepolizumab) or anti-IL-4Rα (dupilumab).
Reference: National Asthma Council Australia – 2024